Randomized Trial Between Histidine-Tryptophan-Ketoglutarate [HTK] and Institute of George Lopez (IGL-1] Perfusion Solutions in Living Donor Liver Transplantation

Category Primary study
JournalJournal of Clinical and Experimental Hepatology
Year 2019
This article has no abstract
Epistemonikos ID: dc283b6df4dcd40cd45af45ba30061a2d59ce9b1
First added on: Feb 10, 2025